FDA officials found that CBD doesn’t fit existing regulations. They want Congress to create new rules, and will allow the exiting market to continue.
The post Huge decision: FDA won’t restrict CBD sales, calls for ‘new regulatory pathway’ to assure safety appeared first on Leafly.
The Trump administration is preparing to move cannabis from Schedule I to Schedule III of…
Based on the ruling, products that are legal federally as well as at the state…
The drug’s history of healing and experimentation stretches from ancient China to American counterculture —…
The new partnership will spotlight the stories of people still behind bars for cannabis, support…
Colombia is moving forward with a controversial plan to euthanize dozens of invasive hippos descended…
Imported hashish sustained mountain economies for centuries—until modern legalization and market economics erased it almost…